J. Y. Chan

发表

Surface activation of factor XII (Hageman factor) — Critical role of high molecular weight kininogen and another potentiator

H. Movat, J. Y. Chan, C. Burrowes, 2005, Agents and Actions.

Coagulation of human plasma by asbestos fibers.

J. Hamilton, H. Movat, J. Y. Chan, 1981, Environmental research.

The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors.

H. Movat, J. Y. Chan, C. Burrowes, 1977, Biochemical and biophysical research communications.

Regulation of expression of human granulocyte/macrophage colony-stimulating factor.

D. Slamon, S. Nimer, D. Golde, 1986, Proceedings of the National Academy of Sciences of the United States of America.

Purification of factor XII (Hageman factor) from human plasma.

H. Movat, J. Y. Chan, John Y.C. Chan, 1976, Thrombosis research.

Von Willebrand disease "stimulating factor" in porcine plasma.

J. Y. Chan, M. E. Muhrer, P. Didisheim, 1968, The American journal of physiology.

Normal-phase high-performance liquid chromatography of porphyrin free acids on silica modified with tetraethylenepentamine.

J. Y. Chan, C. Lim, 1982, Journal of Chromatography A.

Interaction between factor XII (Hageman factor), high molecular weight kininogen and prekallikrein.

H. Movat, J. Y. Chan, C. Burrowes, 1976, Thrombosis research.

Activation of factor XII (Hageman factor): enhancing effect of a potentiator.

H. Movat, J. Y. Chan, C. Burrowes, 1977, Thrombosis research.

High molecular weight kininogen: its inability to correct the clotting of kininogen-deficient plasma after cleavage of bradykinin by plasma kallikrein, plasmin or trypsin.

H. Movat, J. Y. Chan, C. Burrowes, 1979, Thrombosis research.

Regulation ofexpression ofhumangranulocyte/macrophage colony-stimulati ng factor

J. Gasson, J. Y. Chan, 1986 .